BioCompute Project

The BioCompute Object Specification Project led by a team at SMHS has been officially approved for publication as an internationally recognized standard by the Institute of Electrical and Electronics Engineers Standards Association.

A consortium led by GW has been refunded for their BioCompute Object Specification Project, thanks to a $2.2 million, five-year grant from the U.S. Food and Drug Administration.

Researchers from GW, FDA, and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing called BioCompute.

GW and the FDA published an update to the BioCompute Object Specification Project, which provides much-needed standards for communicating high-throughput sequencing computations and data analysis, known as BioCompute Objects.

GW and the FDA have published a BioCompute Object Specification Document for research and clinical trial use, which details a new framework for communication of High-throughput Sequencing computations and data analysis, known as BioCompute Objects. 

Raja Mazumder, Ph.D., and his team host a workshop for more than 300 participants at the NIH to get feedback on biocompute objects.

Raja Mazumder, Ph.D., works with the FDA to create a framework for standardizing computational biology algorithms.